Skip to content
DraconiticResearch
Search Sources API
209,932 studies31 sourcesUpdated 26 min ago

Oncology

5,300 studies557 in 7 days2,546 in 30 days

Filters
Type
Date
Clear

Latest

5,300 studies

  1. Protein pyruvylation: a potential metabolic checkpoint in tumor immunity?
    Ren Liu, Jiamin Yuan, Haigang Jin +5
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMCEurope PMC
  2. Immune Evasion Strategies of Human Poxviruses: A Roadmap for Engineering Low-Immunogenic CAR-Based and iPSC-Derived Cell Products
    Daniil O. Antonov, Marina Yu. Loguinova, Hui Fan +7
    CellsPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  3. Engineered SERPINE1 Overexpression Activates the pp53/p21 Pathway and Promotes a Growth-Restricted, Migratory Phenotype in KRAS-Transformed Renal Proximal Tubular Cells
    Naziba Nuha, Craig E. Higgins, Stephen P. Higgins +2
    BiomoleculesPeer-reviewedCC BY 4.0OncologyCrossref
  4. Prognostic Value of lncRNA H19 in Gastric Cancer: A Systematic Review and Meta-Analysis
    Silu Song, Yi Li, Chenxia Gao +3
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  5. ImmunEscpMap: a gene-centered knowledgebase for immune escape in cancer and viral infection
    Shun Jiang, Shuyue Ma, Yuzhou Feng +9
    Nucleic Acids ResearchPeer-reviewedCC BY-NC 4.0Full textOncologyCrossref
  6. Protease Signatures in Health and Disease: Toward Smart Diagnostic Platforms
    Justyna Janikiewicz, Aneta M. Dobosz, Lennart Brewitz +2
    JACS AuPeer-reviewedCC BY 4.0Full textOncologyCrossref
  7. RNF152 promoter methylation and gene expression in oral premalignant lesions and oral squamous cell carcinoma: implications for epigenetic biomarker development
    Madona Gjona, Seval Turna, Cömert Şen +6
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  8. Advancing Blue‐Light Photoactivatable TAM Kinase Inhibitors for Cancer Treatment: Challenges in Using π ‐Extended Coumarins as Photocleavable Protecting Groups
    Sébastien Billotte, Gaëlle Fontaine, Frédéric Bolze +3
    ChemPhotoChemPeer-reviewedCC BYOncologyHAL
  9. Factors associated with treatment resumption and long-term outcomes after ICU discharge in patients with hematological malignancies
    Ondine Messéant, Mathilde Guégan, Benoit Painvin +6
    Annals of Intensive CarePeer-reviewedCC BY 4.0Full textOncologyHAL
  10. Synthesis, characterization and biological evaluation of newly designed silver(I)-N-heterocyclic carbene (NHC) complexes
    Dorra Abdelmalek, Neslihan Şahin, Bui Minh Thu Ly +7
    Results in ChemistryPeer-reviewedCC BY-NC-ND 4.0Full textOncologyHAL
  11. A genetic platform to deconvolve efficacy and toxicity reveals the on-target effects of CDK11 inhibition in vivo
    Linda Julian, Lisa Crozier, Devon Lukow +35
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  12. NDUFS1 promotes malignant breast cancer behaviors through enhancement of mitochondrial respiration and PROX1/c-Myc signaling
    Yen-Yun Wang, Pang-Yu Chen, Lester Uy Vinzons +8
    iSciencePeer-reviewedCC BY 4.0Full textOncologyCell PressCrossrefPMCEurope PMC
  13. Spatial epigenomics reveals stromal niche-associated regulatory programs across pancreatic neuroendocrine tumor grades
    Dejiang Wang, Xiangjun Di, Fu Gao +13
    iSciencePeer-reviewedCC BY 4.0Full textOncologyCell PressCrossrefEurope PMC
  14. Coordination of cell cycle and hematopoietic differentiation by a HoxA9/Myc/Cdk6 feedback loop
    M.-P. Garcia-Cuellar, R. K. Slany
    bioRxivPreprintCC BYFull textOncologybioRxiv
  15. ESCRT-dependent YAP degradation by AKT blockade overcomes adaptive resistance to RAS(ON) inhibition in pancreatobiliary cancer
    Jack W. Sample, Enis H. Ozmert, Brandon A. Wilbanks +16
    bioRxivPreprintCC BYFull textOncologybioRxivPMC
  16. Hyperactivation of β-catenin rewires mitochondrial fuel selection in liver cancer cells
    Luis Cedeño-Rosario, Queren A. Alcantara, Nicole A. Sierra +18
    bioRxivPreprintCC BYFull textOncologybioRxivPMC
  17. NHE1 sustains leukemia-propagating capacity and mitochondrial fitness in T-cell acute lymphoblastic leukemia
    Majd A. Al-Hamaly, Meghan G. Haney, Yelena Chernyavskaya +8
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxivPMC
  18. GLP1R agonists and vorasidenib converge on peroxynitrite-mediated cytotoxicity in mutant IDH glioma
    C. Taglang, S. Udutha, T. N. Phoenix +3
    bioRxivPreprintAll rights reservedFull textOncologybioRxivPMC
  19. Live immunogenic melanoma cells generated by etoposide treatment upregulate B2M and lose tumor-forming potential
    B. W. Lyon, E. Russo, C. Colbert +8
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  20. The Role of Viral Pathogens in the Promotion of Epithelial-Mesenchymal Transition and Neoplastic Cell Invasion.
    Sharof Tugizov
    VirusesPeer-reviewedCC BYFull textOncologyEurope PMC
  21. MiR-4261 Regulates Granulosa Cell Proliferation Mediated by Progesterone via FZD5 in Human Ovarian Granulosa Cell Line.
    Jiao Yu, Yangyang Zhang, Yanrong Kuai +2
    GenesPeer-reviewedCC BYFull textOncologyEurope PMC
  22. Prognostic significance of the C-reactive protein-albumin-lymphocyte (CALLY) index in primary lung malignancies: a systematic review and meta-analysis with GRADE assessment
    M. Shamohammadi, D. Yarahmadi, F. Naseri Rad +6
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  23. Benign Proliferative Nodules in a Giant Congenital Melanocytic Nevus: Diagnostic Challenge and Management.
    Fenohasina Rakotonandrasana, Holy Tiana Andrianjafitrimo, Onivola Raharolahy +8
    Case reports in dermatological medicinePeer-reviewedCC BYFull textOncologyEurope PMC
  24. Factors associated with early death from de novo metastatic breast cancer in Ontario, Canada.
    Priya Thomas, Brooke Carter, Craig C Earle +9
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadiennePeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  25. National trends in dual de-escalation of axillary surgery and adjuvant radiation in early-stage HR+/HER2- breast cancer.
    Dylan S Brokaw, Leonardo Kozian, Cecilia Chang +5
    Breast cancer research and treatmentPeer-reviewedCC BYFull textOncologyEurope PMC